Cytosorbents - 53 Year Dividend History | CTSO
Historical dividend payout and yield for Cytosorbents (CTSO) since 1971. The current TTM dividend payout for Cytosorbents (CTSO) as of April 25, 2024 is $0.00. The current dividend yield for Cytosorbents as of April 25, 2024 is 0.00%.
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical Products Manufacturing |
$0.045B |
$0.036B |
|
CytoSorbents Corporation is a therapeutic medical device company. It develops adsorbent polymer technology for applications in the medical field, primarily to provide blood purification for the treatment of acute and chronic health complications associated with blood toxicity. The Company's product include CytoSorb, which filters cytokines and treat potentially fatal cytokine storm and BetaSorb, which remove beta2-microglobulin from the blood of patients suffering from chronic kidney failure. CytoSorbents Corporation is headquartered in Monmouth Junction, New Jersey.
|
| Stock Name |
Country |
Market Cap |
PE Ratio |
